Johnson & Johnson’s medtech business and Philips also cited China’s order slowdown for sluggish revenue growth in the second quarter.
GE Healthcare facing pressure in China as hospitals delay orders Read More »
During a second-quarter earnings call Wednesday, new CEO Chuck Divita said the virtual care company is “not yet delivering on its fullest potential.”
Teladoc withdraws 2024 outlook, logs impairment charge amid downturn at BetterHelp Read More »
With an upfront $800 million payment and $325 million in potential milestones, Otsuka Pharmaceutical is acquiring Jnana Therapeutics’ drug discovery platform and rare disease candidate, the companies announced Thursday.
Otsuka Pays Up to $1.1B to Buy Jnana, Adds Drug Discovery Capabilities Read More »
Moderna’s stock price plunged more than 20% in Thursday morning trading after the company lowered its 2024 revenue guidance due to weak demand for its coronavirus vaccine in the second quarter.
Moderna Cuts Full-Year Revenue Guidance as COVID-19 Vaccine Sales Crater in Q2 Read More »
Reiterating his ruling in a prior Inflation Reduction Act case, New Jersey District Court Judge Zahid Quraishi ruled that Novo Nordisk’s participation in the Medicare Drug Price Negotiation Program is of its own free will.
Novo Loses IRA Case as NJ Judge Asserts Price Negotiations Are Voluntary Read More »
Sarepta has been hit with another patent infringement lawsuit, this time from Sanofi and its subsidiary Genzyme alleging that the biotech used protected technology related to AAV vectors.
Sanofi Sues Sarepta Over Elevidys DMD Gene Therapy, Alleges Patent Infringement Read More »
Eli Lilly on Thursday released late-stage data showing a 38% reduction in the risk of heart failure outcomes, as it plays catch-up with Novo Nordisk’s semaglutide which won the FDA’s cardio nod in March.
Lilly’s Tirzepatide Clears Phase III Cardiovascular Study on Heels of Novo Read More »
The Genetic Metabolic Diseases Advisory Committee will meet on Friday to discuss Zevra’s modified scale to describe the efficacy of its drug candidate for the treatment of Niemann-Pick disease type C.
FDA Questions Strength of Evidence Backing Zevra’s Rare Disease Therapy Ahead of Adcomm Read More »
¿Alguna vez te has preguntado quién está detrás de las sensaciones que experimentas al jugar en un casino online? Esos gráficos deslumbrantes, esas mecánicas de juego y esos sonidos tan característicos que nos mantienen pegados a la pantalla …
Generative AI could enhance and accelerate the way people work on clinical trials. In this Q&A, a management consultant shares his insights on benefits, risks and more.
How is Generative AI Transforming Clinical Trial Work? Read More »
